A Phase 1, Randomized, Open Label, Single-Dose Crossover Study to Assess the Relative Bioavailability, Food Effect, and Safety of Capsule Formulations of INF904.

This study is looking for healthy adults to take part. This means we're looking for individuals who don't have any major ongoing health conditions. We want to understand how the medicine works in typical, healthy people before testing it in those with particular illnesses.

To be eligible, you need to be at least 18 years old. There is no upper age limit mentioned, but other health checks might be done to ensure you're in good general health. Both men and women are welcome to participate in this research.

Before you can join, a doctor or nurse will check your health carefully to make sure the study is a safe and good fit for you. This often involves discussions about your health history, a physical examination, and some blood tests.

If you decide to take part, you would receive different forms of the medicine, INF904, at various times. This is called a 'crossover' study, meaning you'll get each different form at different times, so we can compare them directly in the same person. You would likely need to visit the study clinic multiple times, and these visits might include overnight stays or several hours at the clinic. During these visits, nurses and doctors would regularly take blood samples to measure how much of the medicine is in your body. They would also monitor your vital signs, like blood pressure and heart rate, and ask you about how you are feeling to check for any side effects. You would also have specific instructions about when and what to eat, especially around the times you take the medicine, as we are studying the effect of food. The total duration of your participation, including all visits and follow-up, would be fully explained to you before you agree to join.